We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

7 hedge funds and large institutions have $12.1M invested in Apollo Endosurgery, Inc. in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

30% less funds holding

Funds holding: 107 (-3)

44% less capital invested

Capital invested by funds: $21.5M → $12.1M (-$9.38M)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
7
Holders Change
-3
Holders Change %
-30%
% of All Funds
0.17%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
3
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change

APEN Hedge Fund Activity: Q2 2017 in Review

7 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q2 2017, worth a combined $12.1M — down 44% from $21.5M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of APEN and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Bridgeway Capital Management, adding an estimated $40.8K. The largest seller was Novo Holdings A/S, cutting an estimated $857K.

  • 7 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q2 2017, down from 10 in Q1 2017.
  • Funds reported $12.1M of Apollo Endosurgery, Inc. stock for Q2 2017, down 44% quarter-over-quarter.
  • 1 fund opened new Apollo Endosurgery, Inc. positions in Q2 2017 and 4 closed out, a net change of -3 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q2 2017 was Bridgeway Capital Management, an estimated $40.8K added.
  • The largest Apollo Endosurgery, Inc. seller in Q2 2017 was Novo Holdings A/S, an estimated $857K sold.

Based on aggregated 13F filings for Q2 2017.